smoking

Study targets nicotine craving in schizophrenia

Vanderbilt’s Heather Burrell Ward, MD, has received a five-year, $928,000 grant from the National Institute on Drug Abuse to test whether an externally applied magnetic field can reduce nicotine craving in people with schizophrenia.

Enhanced treatment helps fast nicotine metabolizers quit smoking

A study from Vanderbilt researchers has found that enhanced treatment support can help smokers who have more difficulty quitting because they are fast metabolizers of nicotine.

Tindle authors NCI guidance on treatment of cancer patients who smoke

Vanderbilt’s Hilary Tindle, MD, MPH, was one of the key contributors to the new Tobacco Control Monograph from the National Cancer Institute.

Study that investigated whether three smoking cessation drugs could reduce alcohol intake yields unexpected finding

A Vanderbilt study of three proven smoking cessation treatments suggests these medications could play an important role to reduce alcohol use and smoking at the same time.

Smokers have better quit rates with hospital-based interventions than quitline help, but study indicates need for longer follow-up

A health care system model that offered tobacco cessation treatment to smokers being discharged from a hospital produced a higher rate of tobacco abstinence during the three-month program than referral to a state-based telephone quitline, but the advantage disappeared at six months when both treatments produced comparable quit rates, researchers have found.

Study casts doubt on impact of menthol-flavored tobacco ban

Vanderbilt research finds that a ban on the sale of menthol-flavored cigarettes that the U.S. Food and Drug Administration (FDA) is on track to implement may have unintended consequences.

1 2 3